NATIXIS - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIXIS ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$131,728
-51.0%
902
-18.7%
0.00%
-50.0%
Q1 2023$268,666
-89.6%
1,109
-95.0%
0.00%
-75.0%
Q1 2021$2,573,000
-56.9%
22,000
-59.0%
0.01%
-63.6%
Q4 2020$5,972,000
-36.4%
53,722
-32.1%
0.02%
-68.1%
Q3 2020$9,396,00079,1340.07%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 463,000$99,142,0004.55%
Rock Springs Capital Management LP 342,000$73,232,0002.65%
ACUTA CAPITAL PARTNERS, LLC 33,000$7,066,0002.52%
HealthCor Management, L.P. 262,860$56,286,0001.87%
Baker Brothers Advisors 1,169,278$250,377,0001.65%
EMORY UNIVERSITY 11,391$2,439,0001.60%
PACIFIC VIEW ASSET MANAGEMENT, LLC 8,690$1,862,0001.48%
GREAT POINT PARTNERS LLC 40,400$8,651,0001.35%
SHIKIAR ASSET MANAGEMENT INC 15,341$3,285,0001.28%
ARMISTICE CAPITAL, LLC 80,000$17,130,0001.03%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders